Skip to content

Prediction of Abdominal Aortic Aneurysm Shrinkage After Stent-placement With Artificial Intelligence

Prediction of Abdominal Aortic Aneurysm Shrinkage After Endovascular Repair With Artificial Intelligence

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06250998
Acronym
ARTinEVAR
Enrollment
1000
Registered
2024-02-09
Start date
2024-04-03
Completion date
2024-06-30
Last updated
2024-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AAA - Abdominal Aortic Aneurysm

Keywords

AAA, aneurysm shrinkage, EVAR, aneurysm remodeling, artificial intelligence, AI

Brief summary

The goal of this observational study is to find out what factors contribute to a good treatment outcome in patients who have received a stent for their dilation of the main abdominal artery (abdominal aortic aneurysm or AAA). The primary goal of this study is to build a prediction model for abdominal aortic aneurysm shrinkage one year after the treatment.

Interventions

None listed

Sponsors

University Medical Center Groningen
CollaboratorOTHER
Amsterdam UMC, location VUmc
CollaboratorOTHER
Medisch Spectrum Twente
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER
Rijnstate Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years; * Elective, initially technically successful (as described by the ESVS guidelines11), infrarenal EVAR for unruptured infrarenal AAA; * Implanted endograft is a Gore Excluder, Medtronic Endurant, Cook Zenith, Cordis Incraft, Endologix AFX, Jotec E-Tegra, or Vascutek Anaconda endograft; * Follow-up of the AAA of at least one year with imaging of the same modality as the preoperative imaging; * Axial reconstructions of preoperative CT angiography available, preferably in the arterial phase and with 3 mm or smaller slice thickness.

Exclusion criteria

* Patients with ruptured or symptomatic AAA; * Patients that were treated with fenestrated or branched endografts, iliac branched devices, non-CE marked devices within trial setting, other endografts (EVAS cases) or chimney procedures; * Acute procedures; * Reintervention before one year follow-up; * Revision cases after previous open or endovascular aneurysm repair of an AAA;

Design outcomes

Primary

MeasureTime frameDescription
Prediction model for AAA shrinkagePreoperative, peroperative and postoperative (until 1-year visit) dataA prediction model to predict AAA shrinkage one-year after EVAR, it can consist of multiple CTA-scans and/or clinical data.

Countries

Netherlands, Sweden

Contacts

Primary ContactRianne E van Rijswijk, MSc
contact@radarconsortium.com0031880057282

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026